Telomerase activity in disseminated prostate cancer cells
- 9 May 2006
- journal article
- Published by Wiley in BJU International
- Vol. 97 (6) , 1309-1313
- https://doi.org/10.1111/j.1464-410x.2006.06194.x
Abstract
To analyse telomerase activity in disseminated prostate cancer cells isolated from bone marrow aspirates taken from men with localized prostate cancer before radical prostatectomy (RP).Disseminated epithelial prostate cancer cells were isolated from bone marrow aspirates from 69 men with localized prostate cancer before RP, by magnetic column-chromatography enrichment, followed by isolation of fluorescently labelled epithelial cells by micropipetting. We used pools of 10 non-epithelial bone marrow cells after tumour cell enrichment as control samples. These pure cell pools were tested for the presence of telomerase activity.In all, 49 of the patient samples contained disseminated prostate cancer cells. Homogeneous pools of 10 cells were obtained from 35 of these; 49% of the 35 specimens showed telomerase activity, whereas all five control samples did not. Telomerase activity in the 35 samples was not significantly associated with Gleason score, preoperative prostate-specific antigen level, tumour stage, or surgical margin status. Follow-up is continuing to assess an association with disease recurrence.This work shows the feasibility of isolating disseminated cancer cells for analysing individual or pooled cells. Compared to tissue staining, where telomerase is detected in 80-90% of samples, we found lower rates of telomerase activity in the disseminated tumour cells (49%). Telomerase-negative cells might provide information about cell dormancy, as telomerase is a marker of cell proliferation in immortal and cancer cells. Telomerase-positive cells might predict early disease recurrence, but a longer follow-up is needed to test this possibility.Keywords
This publication has 24 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Combined transcriptome and genome analysis of single micrometastatic cellsNature Biotechnology, 2002
- TELOMERASE IN UROLOGICAL MALIGNANCYJournal of Urology, 2001
- Determination of telomerase activity for differential analysis of multifocal renal cell carcinomasKidney International, 1999
- Telomerase activity and telomere lengths: Alterations in renal cell carcinomasKidney International, 1999
- CLINICAL AND MOLECULAR FOLLOWUP AFTER RADICAL RETROPUBIC PROSTATECTOMYJournal of Urology, 1999
- FOCAL INTRATUMORAL HETEROGENEITY FOR TELOMERASE ACTIVITY IN HUMAN PROSTATE CANCERJournal of Urology, 1999
- TELOMERASE ACTIVITY, TELOMERE LENGTH, AND DNA PLOIDY IN PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN)Journal of Urology, 1998
- THE VALUE OF A REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION ASSAY IN PREOPERATIVE STAGING AND FOLLOWUP OF PATIENTS WITH PROSTATE CANCERJournal of Urology, 1998
- The use of RT‐PCR for prostate‐specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancerBritish Journal of Urology, 1996